Impact of timing of trastuzumab initiation on long-term outcome of patients with early-stage HER2-positive breast cancer: the “one thousand HER2 patients” project

Impact of timing of trastuzumab initiation on long-term outcome of patients with early-stage HER2-positive breast cancer: the “one thousand HER2 patients” projectImpact of timing of trastuzumab initiation on long-term outcome of patients with early-stage HER2-positive breast cancer: the “one thousand HER2 patients” project, Published online: 18 May 2018; doi:10.1038/s41416-018-0114-xImpact of timing of trastuzumab initiation on long-term outcome of patients with early-stage HER2-positive breast cancer: the “one thousand HER2 patients” project

Source: British Journal of Cancer - May 18, 2018 Category: Cancer & Oncology Authors: Giuseppe Gullo Naomi Walsh David Fennelly Reetesh Bose Janice Walshe Dimitrios Tryfonopoulos Kate O ’Mahony Lisa Hammond Nuno Silva Deirdre McDonnell Josephine Ballot Cecily Quinn Enda W. McDermott Denis Evoy Ruth Prichard James Geraghty John Amstrong J Source Type: research